Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2002
Cutting edge: a murine, IL-12-independent pathway of IFN-gamma induction by gram-negative bacteria based on STAT4 activation by Type I IFN and IL-18 signalingMarina A Freudenberg, Thomas Merlin, Christoph Kalis, et al.Journal of Endotoxin Research|October 28, 2003
Role of interferons in LPS hypersensitivityMarina A Freudenberg, Christoph Kalis, Yolande Chvatchko, et al.European Journal of Immunology|March 5, 2003
Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in miceChristoph Kalis, Benoit Kanzler, Annalisa Lembo, et al.Infection and Immunity|September 23, 2003
Differential contribution of Toll-like receptors 4 and 2 to the cytokine response to Salmonella enterica serovar Typhimurium and Staphylococcus aureus in miceAnnalisa Lembo, Christoph Kalis, Carsten J Kirschning, et al.Journal of Pharmaceutical and Biomedical Analysis|July 18, 2009
Reduction of matrix interferences by the combination of chaotropic salt and DMSO in a broadly applicable target-based ELISA for pharmacokinetic studies of therapeutic monoclonal antibodiesJulie Doucet, Jasna Canadi, Christoph Kalis, et al.Molecular Immunology|November 11, 2006
Stimulation of mast cells via FcvarepsilonR1 and TLR2: the type of ligand determines the outcomeKerstin Fehrenbach, Fillip Port, Gordon Grochowy, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnesChristoph Kalis, Marina Gumenscheimer, Nikolaus Freudenberg, et al.Plos One|June 30, 2012
TLR9-dependent and independent pathways drive activation of the immune system by Propionibacterium acnesSandrine Tchaptchet, Marina Gumenscheimer, Christoph Kalis, et al.Nature Immunology|May 17, 2005
CD14 is required for MyD88-independent LPS signalingZhengfan Jiang, Philippe Georgel, Xin Du, et al.European Journal of Immunology|March 1, 2006
R-form LPS, the master key to the activation ofTLR4/MD-2-positive cellsMichael Huber, Christoph Kalis, Simone Keck, et al.Pageof 2